Cargando…
CD63(+) Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
Tamoxifen remains the most effective treatment for estrogen receptor α (ERα)‐positive breast cancer. However, many patients still develop resistance to tamoxifen in association with metastatic recurrence, which presents a tremendous clinical challenge. To better understand tamoxifen resistance from...
Autores principales: | Gao, Yuan, Li, Xiaoju, Zeng, Cheng, Liu, Chenlin, Hao, Qiang, Li, Weina, Zhang, Kuo, Zhang, Wangqian, Wang, Shuning, Zhao, Huadong, Fan, Dong, Li, Meng, Zhang, Yingqi, Zhang, Wei, Zhang, Cun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610308/ https://www.ncbi.nlm.nih.gov/pubmed/33173749 http://dx.doi.org/10.1002/advs.202002518 |
Ejemplares similares
-
FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
por: Liu, Chenlin, et al.
Publicado: (2021) -
Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
por: Li, Xiaoju, et al.
Publicado: (2022) -
Genome-Wide Investigation of Genes Regulated by ERα in Breast Cancer Cells
por: Wang, Shuning, et al.
Publicado: (2018) -
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
por: Li, Xiaoju, et al.
Publicado: (2018) -
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer
por: Gao, Yuan, et al.
Publicado: (2018)